Your browser doesn't support javascript.
loading
Targeted DNA-seq and RNA-seq of Reference Samples with Short-read and Long-read Sequencing.
Gong, Binsheng; Li, Dan; Labaj, Pawel P; Pan, Bohu; Novoradovskaya, Natalia; Thierry-Mieg, Danielle; Thierry-Mieg, Jean; Chen, Guangchun; Bergstrom Lucas, Anne; LoCoco, Jennifer S; Richmond, Todd A; Tseng, Elizabeth; Kusko, Rebecca; Happe, Scott; Mercer, Timothy R; Pabón-Peña, Carlos; Salmans, Michael; Tilgner, Hagen U; Xiao, Wenzhong; Johann, Donald J; Jones, Wendell; Tong, Weida; Mason, Christopher E; Kreil, David P; Xu, Joshua.
Afiliación
  • Gong B; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA.
  • Li D; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA.
  • Labaj PP; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
  • Pan B; Bioinformatics Research, Institute of Molecular Biotechnology, Boku University Vienna, Vienna, Austria.
  • Novoradovskaya N; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA.
  • Thierry-Mieg D; Agilent Technologies, Inc., 11011 N Torrey Pines Rd., La Jolla, CA, 92037, USA.
  • Thierry-Mieg J; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD, 20894, USA.
  • Chen G; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD, 20894, USA.
  • Bergstrom Lucas A; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, 5323 Harry Hine Blvd., Dallas, TX, 75390, USA.
  • LoCoco JS; Agilent Technologies, Inc., 5301 Stevens Creek Blvd., Santa Clara, CA, 95051, USA.
  • Richmond TA; Illumina Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
  • Tseng E; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., 4300 Hacienda Dr., Pleasanton, CA, 94588, USA.
  • Kusko R; PacBio, San Francisco, USA.
  • Happe S; Cellino Bio, 750 Main Street, Cambridge, MA, 02143, USA.
  • Mercer TR; Agilent Technologies, Inc., 1834 State Hwy 71 West, Cedar Creek, TX, 78612, USA.
  • Pabón-Peña C; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, Australia.
  • Salmans M; Agilent Technologies, Inc., 5301 Stevens Creek Blvd., Santa Clara, CA, 95051, USA.
  • Tilgner HU; Illumina Inc., 5200 Illumina Way, San Diego, CA, 92122, USA.
  • Xiao W; Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.
  • Johann DJ; Center for Neurogenetics, Weill Cornell Medicine, New York, NY, USA.
  • Jones W; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, 94304, USA.
  • Tong W; Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
  • Mason CE; Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301W Markham St., Little Rock, AR, 72205, USA.
  • Kreil DP; Q squared Solutions Genomics, 2400 Elis Road, Durham, NC, 27703, USA.
  • Xu J; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA.
Sci Data ; 11(1): 892, 2024 Aug 16.
Article en En | MEDLINE | ID: mdl-39152166
ABSTRACT
Next-generation sequencing (NGS) has revolutionized genomic research by enabling high-throughput, cost-effective genome and transcriptome sequencing accelerating personalized medicine for complex diseases, including cancer. Whole genome/transcriptome sequencing (WGS/WTS) provides comprehensive insights, while targeted sequencing is more cost-effective and sensitive. In comparison to short-read sequencing, which still dominates the field due to high speed and cost-effectiveness, long-read sequencing can overcome alignment limitations and better discriminate similar sequences from alternative transcripts or repetitive regions. Hybrid sequencing combines the best strengths of different technologies for a more comprehensive view of genomic/transcriptomic variations. Understanding each technology's strengths and limitations is critical for translating cutting-edge technologies into clinical applications. In this study, we sequenced DNA and RNA libraries of reference samples using various targeted DNA and RNA panels and the whole transcriptome on both short-read and long-read platforms. This study design enables a comprehensive analysis of sequencing technologies, targeting protocols, and library preparation methods. Our expanded profiling landscape establishes a reference point for assessing current sequencing technologies, facilitating informed decision-making in genomic research and precision medicine.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Secuenciación de Nucleótidos de Alto Rendimiento Límite: Humans Idioma: En Revista: Sci Data Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Secuenciación de Nucleótidos de Alto Rendimiento Límite: Humans Idioma: En Revista: Sci Data Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido